In-licensing
Up-to-date access to technology licensing opportunities worldwide.
- In-licensing
- Browse
Licensing opportunities
Seeking opportunities for consumer healthcare products and molecules with Rx-to-OTC switch potential
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential. More
APR is interested to in-license new early stage, innovative and patent protected products/technologies (preferably off patent or close to expiry) for oral, topical or transdermal administration More
Related Reports
Market Research Reports provided by reports.innovaro.com
Oct 2010 - 112 pages - $7,600
Sep 2011 - 39 pages - $250
Sep 2010 - 37 pages - $250
Jan 2011 - 20 pages - $340
Jan 2011 - 54 pages - $340
Sep 2011 - 40 pages - $250
Sep 2011 - 42 pages - $250
Sep 2010 - 38 pages - $250
Sep 2010 - 37 pages - $250
Sep 2011 - 43 pages - $250
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us